PT84818B - Processo para a preparacao de derivados de di-hidro-oxazol, di-hidro-tiazol e di-hidro-imidazol - Google Patents

Processo para a preparacao de derivados de di-hidro-oxazol, di-hidro-tiazol e di-hidro-imidazol

Info

Publication number
PT84818B
PT84818B PT84818A PT8481887A PT84818B PT 84818 B PT84818 B PT 84818B PT 84818 A PT84818 A PT 84818A PT 8481887 A PT8481887 A PT 8481887A PT 84818 B PT84818 B PT 84818B
Authority
PT
Portugal
Prior art keywords
dihydro
thiazol
oxazole
hydro
preparing
Prior art date
Application number
PT84818A
Other languages
English (en)
Other versions
PT84818A (en
Inventor
John Michael Berge
Lee James Beeley
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of PT84818A publication Critical patent/PT84818A/pt
Publication of PT84818B publication Critical patent/PT84818B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PT84818A 1986-05-03 1987-05-04 Processo para a preparacao de derivados de di-hidro-oxazol, di-hidro-tiazol e di-hidro-imidazol PT84818B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868610909A GB8610909D0 (en) 1986-05-03 1986-05-03 Compounds

Publications (2)

Publication Number Publication Date
PT84818A PT84818A (en) 1987-06-01
PT84818B true PT84818B (pt) 1989-12-29

Family

ID=10597340

Family Applications (1)

Application Number Title Priority Date Filing Date
PT84818A PT84818B (pt) 1986-05-03 1987-05-04 Processo para a preparacao de derivados de di-hidro-oxazol, di-hidro-tiazol e di-hidro-imidazol

Country Status (12)

Country Link
US (1) US4861789A (pt)
EP (1) EP0251453B1 (pt)
JP (1) JPS62267270A (pt)
AU (1) AU600939B2 (pt)
DE (1) DE3767789D1 (pt)
DK (1) DK227487A (pt)
ES (1) ES2031890T3 (pt)
GB (1) GB8610909D0 (pt)
GR (1) GR3001416T3 (pt)
NZ (1) NZ220179A (pt)
PT (1) PT84818B (pt)
ZA (1) ZA873169B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034406A (en) * 1989-09-26 1991-07-23 Allergan, Inc. Method for reducing or maintaining intraocular pressure
US5066664A (en) * 1990-02-28 1991-11-19 Allergan, Inc. 2-(hydroxy-2-alkylphenylamino)-oxazolines and thiazolines as anti-glaucoma and vasoconstrictive agents
DK148292D0 (da) * 1992-12-09 1992-12-09 Lundbeck & Co As H Forbindelser
US5580892A (en) * 1993-10-22 1996-12-03 Allergan Method for using 2-(2-alkylphenylamino)-oxazolines as adrenergic agents
DE69524223T2 (de) * 1994-07-11 2002-08-22 Allergan Sales, Inc. Bicyclische derivate mit starrer konformation und adamantane als alpha-2-adrenergische blockierende agenzien
US6150389A (en) * 1994-07-11 2000-11-21 Allergan Sales, Inc. Comformationally rigid bicyclic and adamantane derivatives useful as α2 -adrenergic blocking agents
DE19514579A1 (de) 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
US5677321A (en) * 1996-02-29 1997-10-14 Synaptic Pharmaceutical Corporation 5- and 6-(2-imidazolin-2-ylamino) and -(2-thiazolin-2-ylamino)-benzothiazoles as alpha-2 adrenergic ligands
WO2007093292A2 (en) * 2006-02-15 2007-08-23 Bayer Cropscience Ag Insecticidal substituted amino heterocyclic and heteroaryl derivatives
EP1988080A1 (en) * 2007-05-03 2008-11-05 Bayer CropScience AG Insecticidal substituted 2-aminoindanes
EP2120576A2 (en) * 2007-05-25 2009-11-25 Basf Se Aminoazoline and urea derivatives for combating animal pests
CN101821254B (zh) * 2007-08-15 2013-10-09 阿勒根公司 肾上腺素能化合物
KR20100046256A (ko) * 2007-08-15 2010-05-06 알러간, 인코포레이티드 치료 조성물
CA2696315A1 (en) * 2007-08-15 2009-02-19 Allergan, Inc. Heterocyclyl substituted fused carbocyles useful in the treatment of conditions such as glaucoma and pain
JP5480819B2 (ja) * 2008-01-18 2014-04-23 アラーガン インコーポレイテッド 選択的サブタイプアルファ２アドレナリンアゴニスト及びその使用方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2870161A (en) * 1957-07-08 1959-01-20 Pfizer & Co C 2-(1-indanyl amino)-oxazolines
US2870159A (en) * 1957-07-08 1959-01-20 Pfizer & Co C Hydrogenated 2-(1-naphthylamino)-oxazolines
US2883410A (en) * 1957-07-08 1959-04-21 Pfizer & Co C N-(1-indanyl)-n'-(beta-substituted ethyl)-ureas
DE1195323B (de) * 1963-06-24 1965-06-24 Thomae Gmbh Dr K Verfahren zur Herstellung von 2-[5', 6', 7', 8'-Tetrahydronaphthyl-(1')-amino]-imidazolin und seinen Salzen
US3432600A (en) * 1963-09-30 1969-03-11 Du Pont Partially reduced 2-(1-napthylamino) oxazoline,indanylethylureas,and indanylaminooxazoline
US3679798A (en) * 1964-02-28 1972-07-25 Du Pont Composition comprising arylaminooxazoline and antichloligeneric agent
DE1670753A1 (de) * 1966-09-27 1970-07-16 Bayer Ag Verfahren zur Herstellung von 2-Cycloalkylaminooxazolinen
DE1670751A1 (de) * 1966-09-27 1970-12-23 Bayer Ag Verfahren zur Herstellung von 2-Phenylamino-2-oxazolinen
US3882229A (en) * 1972-07-21 1975-05-06 Nordmark Werke Gmbh Composition and method for shrinking mucous membranes
JPS54151990A (en) * 1978-04-17 1979-11-29 Beiersdorf Ag Novel condensated nitrogenncontained heterocyclic compound and its manufacture

Also Published As

Publication number Publication date
DK227487D0 (da) 1987-05-04
EP0251453A2 (en) 1988-01-07
AU600939B2 (en) 1990-08-30
GR3001416T3 (en) 1992-09-25
DK227487A (da) 1987-11-04
GB8610909D0 (en) 1986-06-11
ES2031890T3 (es) 1993-01-01
EP0251453B1 (en) 1991-01-30
PT84818A (en) 1987-06-01
ZA873169B (en) 1988-04-27
EP0251453A3 (en) 1988-09-28
JPS62267270A (ja) 1987-11-19
DE3767789D1 (de) 1991-03-07
AU7247987A (en) 1987-11-05
NZ220179A (en) 1989-10-27
US4861789A (en) 1989-08-29

Similar Documents

Publication Publication Date Title
PT82890B (pt) Processo para a preparacao de novos derivados de n-aralquil-piperidinametanol
FI873180A7 (fi) Uudet hetratsepiinit ja menetelmä niiden valmistamiseksi.
PT84273B (pt) Processo para a preparacao de derivados da dicloroanilina
BR8907517A (pt) Processo para a preparacao de amonia
KR880003938A (ko) 에리트로마이신 a 유도체 및 그의 제조 방법
PT88224A (pt) Processo para a preparacao de derivados fenil-tiadiazinona, oxadiazinona e triazinona
PT89780A (pt) Processo para a preparacao de derivados da tetrahidroisoquinolina
PT84561B (pt) Processo aperfeicoado para a preparacao de derivados macrolidos
PT96411A (pt) Processo para a preparacao de derivados de azaoxindole
PT84818B (pt) Processo para a preparacao de derivados de di-hidro-oxazol, di-hidro-tiazol e di-hidro-imidazol
PT84124B (pt) Processo para a preparacao duma composicao estavel de nicorandilo
ES552525A0 (es) Un metodo para preparar derivados de cefem
FI863776A7 (fi) Menetelmä 7-aminomitosaanijohdannaisten valmistamiseksi.
PT82445B (pt) Processo para a preparacao de novos derivados glicopeptidicos
PT88180A (pt) Processo para a preparacao de derivados alquilaminoalcoxifenilo
PT89927A (pt) Processo para a preparacao de agentes citotoxicos especificados para celulas
BR8706915A (pt) Processo para a preparacao de derivados metoxibenzofenona,metoxibenzofenonas e composto
PT84587B (pt) Processo para preparacao de uma enzima fibrinolitica
PT96322A (pt) Processo para a preparacao de derivados de glicerol
PT91205A (pt) Processo para a preparacao de 2-aminopurina
PT84459B (pt) Processo para a preparacao de derivados de ciclopropano 1,1-dissubstituidos
BR8701512A (pt) Processo para a preparacao de betume
PT85608A (pt) Processo para a preparacao de derivados de fenil-etanolamina
PT83531B (pt) Processo para a preparacao de derivados de dicloroanilina
PT84590B (pt) Processo para a preparacao de uma enzima fibrinolitica

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19911226